The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter randomized phase II trial assessing the efficacy and safety of mCapOX plus cetuximab and mFOLFOX6 plus cetuximab as first-line treatment for patients with RAS/BRAF wild-type metastatic colorectal cancer: Primary results of the CAPCET study.
 
Yuwen Zhou
No Relationships to Disclose
 
Ping Chen
No Relationships to Disclose
 
Jin Wang
No Relationships to Disclose
 
Yongdong Jin
No Relationships to Disclose
 
Yan Li
No Relationships to Disclose
 
Chuan Chen
No Relationships to Disclose
 
Hong Qiu
No Relationships to Disclose
 
Yanmin Shen
No Relationships to Disclose
 
Qing Qiao
No Relationships to Disclose
 
Hao Liu
No Relationships to Disclose
 
Ellen Huang
No Relationships to Disclose
 
Lin Xie
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose
 
Xin Chen
No Relationships to Disclose
 
Lei Yang
No Relationships to Disclose
 
Li Zhang
No Relationships to Disclose
 
Xiuyong Liao
No Relationships to Disclose
 
Zhang Lei
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Meng Qiu
No Relationships to Disclose